Has Andrei Buna, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,802 in general payments to Andrei Buna, MD across 224 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Andrei Buna, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Andrei Buna, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Andrei Buna, MD

Obstetrics & Gynecology · Randolph, NJNPI 1043309081

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Celularity Inc. at 31.0% of the total. Reporting peaked in 2019 at $2,004 and has fallen 99.3% since, to $13 in 2025. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,802in general payments, 2019–2025

Across 224 payments — averaging $30.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Celularity Inc.$2K
Olympus Corporation Of The Americas$890
Amgen$584
AbbVie$520
Pfizer$425
Millicent US Inc$319
plus $2K from 24 others

What the payments were for

Speaking & faculty fees$2,10031%
Travel & lodging$5308%
Food & beverage$4,03459%
Education$1382%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Celularity Inc.	7	$2,110
Olympus Corporation Of The Americas	9	$890
Amgen	11	$584
AbbVie(2 entities)	40	$520
Pfizer	24	$425
Millicent US Inc	21	$319
Mayne Pharma Commercial LLC	19	$261
Therapeuticsmd, Inc.	11	$167
Sumitomo Pharma America, Inc.	10	$154
Myovant Sciences Inc.	10	$147
Merck	10	$143
Astellas Pharma US Inc	7	$140
Dysis Medical, Inc.	2	$137
Pacira Pharmaceuticals Incorporated	1	$123
Exeltis, USA Inc.	8	$110
Evofem Biosciences, Inc.	6	$85
Avion Pharmaceuticals	6	$78
Davol Inc.	2	$75
Agile Therapeutics, Inc.	3	$45
Organon	2	$43
Vertical Pharmaceuticals, LLC	3	$42
Hologic Sales And Service, LLC	2	$37
Roche Diagnostics Corporation	2	$34
Biohaven Pharmaceutical Holding Company Ltd.	2	$29
Exact Sciences	1	$25
Bayer	1	$22
AMAG Pharmaceuticals, Inc.	1	$15
Biohaven Pharmaceuticals, Inc.	1	$14
Novum Pharma, LLC	1	$14
Ascend Therapeutics US, LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,802 in reported general payments places this provider in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.

See all obstetrics & gynecology providers in New Jersey →

Medicare billing

Part B allowed, 2024

$4,973

Medicare patients

Services billed

102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Estradiol	30	$3,298
ProgesteroneProgesterone, Micronized	11	$487
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet	11	$245
Fluconazole	12	$54

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Randolph

Jennifer AshtonEnglewood$1.5M
Geoffrey BowersVoorhees$228K
Neha DeshpandePlainsboro$206K
Paula JasionowskiVoorhees$193K
Justin ChuraSwedesboro$179K
Andrea VentolaFlorham Park$145K
Aiman ShiladPaterson$100K
Patrick CulliganMorristown$93K
Dipak DelvadiaCherry Hill$86K
Susan PitmanWest Orange$77K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →